Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Managing Director of Hatteras Discovery and Venture Partner at Hatteras Venture Partners
Professor, Michigan State University
VP of Venture Capital, Pfizer Inc.
How hard is it to detect and analyze individual circulating tumor cells? Find out what’s next in cancer diagnostics and why such work has the potential to revolutionize how cancer is diagnosed and treated. Invited speakers are Peter Kuhn, a professor at the Scripps Research Institute, and Thomas Broudy, chief scientific officer at Molecular Response. Event is free, but please register online here.